Healthcare
-
A Kentucky federal court granted preliminary approval on Thursday to a settlement in which Omnicare Inc. agreed to pay $20 million to resolve a 13-year-old securities suit that at one point made its way to the U.S. Supreme Court… Read this piece in its entirety at Law360.
-
Fitness and wellness program provider Tivity Health lost a bid to kill a stock-drop suit on Monday when a Tennessee federal judge said allegations of “suspicious stock sales” by executives, including Tivity’s chief legal officer, bolstered the case against the company… Read this piece in its entirety at Law360.
-
A proposed class of investors hit Corbus Pharmaceutical Holdings Inc. and two of its top executives with a securities suit in Massachusetts federal court Tuesday alleging that the company and its officers concealed negative results in clinical trials of its flagship drug… Read this piece in its entirety at Law360.
-
Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal court hadn’t correctly analyzed the obviousness of a key claim when deciding to invalidate the patent… Read this piece in its entirety at Law360.
-
The America Invents Act doesn’t stop patent challengers who won at the Patent Trial and Appeal Board from pursuing their winning arguments in court, and blocking that judicial path would lead to “absurd results,” a group of generic-drug makers told the Federal Circuit on Tuesday… Read this piece in its entirety at Law360.
Mike LaSusa 